JCI-日立

GEA equips new Biopharma plant in Ukraine with new separator technology for blood plasma fractionation

2021-04-07
GEA supports its long-standing partner Biopharma from Ukraine with the delivery of further state-of-the-art separators for blood plasma fractionation. Biopharma is the Ukrainian pharmaceutical company focused on the development and production of drugs based on human plasma. The equipment has been installed at Biopharma's new plant in Bila Tserkva. The new equipment will not only enable Biopharma to supply Ukraine with high-quality products, but also to take a leading position in the world ranking of high-tech plasma processors. Separators already supplied, such as a GEA separator BKA 6 for blood plasma fractionation in 2004, two Pathfinders PSC 8 (probiotics) in 2014, and separators PKI 45, BKB 28, one BKA 45 and two BKI 45 to date, represent successful cooperation of GEA with the Ukrainian company for more than 15 years.
To view the complete content, please log in.
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
JARN
 
 
Midez CAC